StemCells Inc Profile

0.0070  2.08%
10 Days Price Trend
February 6, 2016

StemCells Inc Market Sensitivity

As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, StemCells Inc will likely underperform.
One Month Beta |Analyze StemCells Inc Demand Trend
Check current 30 days StemCells Inc correlation with market (NYSE)
β = 1.5708
StemCells Inc Large BetaStemCells Inc Beta Legend

StemCells Inc Risk Profiles

Key Fundamentals

StemCells Inc Against Markets

StemCells Inc Leadership

Martin McGlynn CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
More Executives

StemCells Inc Diversification Suggestion

Use StemCells Inc to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of StemCells Inc to be traded at $0.3168 in 30 days

StemCells Inc Daily Price Distribution

The median price of StemCells Inc for the period between Thu, Jan 7, 2016 and Sat, Feb 6, 2016 is 0.34 with a coefficient of variation of 7.07. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 0.34, and mean deviation of 0.02. The Stock received some media coverage during the period.

StemCells Inc Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 69 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 34.82 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 108.81 M outstanding shares of which 3.09 M shares are at this time shorted by private and institutional investors with about 3.66 trading days to cover.
Current Sentiment - STEM
StemCells Inc Investor Sentiment
Most of Macroaxis users are at this time bullish on StemCells Inc. What is your outlook on investing in StemCells Inc? Are you bullish or bearish?
98% Bullish
2% Bearish
StemCells IncSkip  Hide
Past Market
Performance (0 to 100)
Chance of
StemCells Inc. a biopharmaceutical company researches develops and commercializes cellbased therapeutics and related technologies for stem cellbased research and drug discovery and development. more
NameStemCells Inc
InstrumentUSA Stock
ExchangeNasdaq Capital Markets
Contact Number510 456 4000
Analyst ConsensusStrong Buy 4 Opinions
Macroaxis AdviceStrong Sell Under Valued
CurrencyUSD - US Dollar
StemCells Inc Analyst Recommendations
Target PriceAdvice# of Analysts
1.875Strong Buy4
StemCells Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
StemCells Inc Analyst Advice  
StemCells Inc Alerts
Equity Alerts and Improvement Suggestions
StemCells Inc generates negative expected return over the last 30 days
StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has high historical volatility and very poor performance
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 971.08 K. Net Loss for the year was (37.56 M) with profit before overhead, payroll, taxes, and interest of 1.01 M.
STEMCELLS INC currently holds about 21.19 M in cash with (30.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Latest headline from Ian Massey President and CEO of StemCells Inc. to Participate on a ...
Upcoming Events
StemCells Inc Upcoming Company Events
Upcoming Quarterly ReportMarch 21, 2016
Next Earnings ReportMay 3, 2016
StemCells Inc Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.09March 21, 2016
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Inc Earnings Estimate  
Research Report
Get StemCells Inc research report
Get StemCells Inc research report. Reports are available in pdf format and contain fundamental information about the equity. Click Research Report to view
Pair Trading
StemCells Inc Pair Trading Analysis
Correlation analysis and pair trading evaluation for StemCells Inc and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing idea could easily outperform a given market if properly optimized
Explore Investing Ideas  
StemCells Inc Corporate Directors
Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director